Acadia Pharmaceuticals | ACAD - Pe Prix À Revenus

Prix De L'Action
21.85
Variation Quotidienne
-0.60 -2.67%
Mensuellement
-1.58%
Annuel
46.55%
Q2 Prévisions
21.49




Pe Changement Date
Acadia Pharmaceuticals 11.61 2.09 2025-12
ALKERMES 19.54 4.64 2025-12
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Biogen 13.7 0.32 2026-03
BioMarin Pharmaceutical 19.24 0.21 2025-12
Bristol-Myers Squibb 9.08 0.2 2026-03
Cara Therapeutics 27.77 117.09 2021-09
Corcept Therapeutics 113.58 71.67 2026-03
Eisai 26.63 0.46 2025-12
Eli Lilly 40.27 0.06 2026-03
Incyte 15.35 0.51 2026-03
J&J 24.53 0.91 2026-03
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 835.47 802.2 2025-12
Pfizer 14.48 5.18 2025-12
Prothena 22.11 11.37 2022-03
PTC Therapeutics 9.98 3.25 2025-12
Sarepta Therapeutics 27.27 0 2025-09
Vanda Pharmaceuticals 16.79 7.07 2023-06
Vertex Pharmaceuticals 26.15 2.22 2025-12